Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Article

The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue Subscale): Validity and Reliability of the Iranian Version

Meysami A.a · Yari H.b · Haghighat S.c · Montazeri A.d

Author affiliations

a Department of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran; b Department of Physical Medicine and Rehabilitation, Shiraz University of Medical Sciences, Shiraz, Iran; c Department of Cancer Quality of Life, Breast Cancer Research Center, ACER, Tehran, Iran; d Mental Health Research Group, Health metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran

Related Articles for ""

Oncol Res Treat 2017;40:789-793

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Article

Received: November 08, 2016
Accepted: July 19, 2017
Published online: November 29, 2017
Issue release date: December 2017

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2

ISSN: 2296-5270 (Print)
eISSN: 2296-5262 (Online)

For additional information: https://www.karger.com/ORT

Abstract

Background: The aim of this study was to translate and validate the Functional Assessment of Chronic illnesses Therapy-Fatigue (FACIT-fatigue subscale) in Iran. Methods: The Persian version of the FACIT-fatigue scale was developed using the forward-backward translation method. The questionnaire was then presented to a consecutive sample of breast cancer patients (n = 208) attending the Iranian Center of Breast Cancer (ICBC). The reliability was assessed by internal consistency and test-retest using Cronbach's α and intraclass correlation coefficient (ICC), respectively. Convergent validity was examined by correlation between the FACIT-fatigue scale and the Hospital and Depression Scale (HADS). In addition, discriminant validity was evaluated by the ability of the scale to differentiate between patients who differed in disease stage. Results: The internal consistency of the questionnaire was excellent (Cronbach's α = 0.92). The ICC for the FACIT-fatigue was 0.84. Strong correlations were observed between FACIT-fatigue and depression (r = -0.69) and anxiety (r = -0.72) scores. The FACIT-fatigue discriminated well between subgroups of patients who differed in stage (p < 0.001) and probable caseness of anxiety and depression disease (p < 0.001). Conclusion: The Iranian version of the FACIT-fatigue subscale is a valid and reliable instrument to measure fatigue in cancer patients.

© 2017 S. Karger GmbH, Freiburg


References

  1. Escalante CP, Manzullo EF: Cancer-related fatigue: The approach and treatment. J Gen Intern Med 2009;24 Suppl 2:S412-S416.
  2. Winningham ML, Nail LM, Burke MB. Fatigue and the cancer experience: The state of the knowledge. Oncol Nurs Forum 1994;21:23-36.
    External Resources
  3. Tan X, Xia F: Long-term fatigue state in postoperative patients with breast cancer. Chin J Cancer Res 2014;26:12-16.
  4. Minton O, Stone P: A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 2009;20:17-25.
  5. Yellen SB, Cella D, Webster K, et al.: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63-74.
  6. Cella D, Yount S, Sorensen M, et al.: Validation of the Functional Assessment of Chronic Illness Therapy Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811-819.
    External Resources
  7. Hewlett S, Hehir M, Kirwan JR: Measuring fatigue in rheumatoid arthritis: A systematic review of scales in use. Arthritis Rheum 2007;57:429-439.
  8. Chandran V, Bhella S, Schentag C, Gladman DD: Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 2007;66:936-939.
  9. Signorovitch J, Brainsky A, Grotzinger KM: Validation of the FACIT-Fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia. Qual Life Res 2011;20:1737-1744.
  10. Friedman JH, Alves G, Hagell P, et al.: Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord 2010;25:805-822.
  11. Hagell P, Hoglund A, Reimer J, et al.: Measuring fatigue in Parkinson's disease: A psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage 2006;32:420-432.
  12. Tinsley A, Macklin EA, Korzenik JR, Sands BE: Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011;34:1328-1336.
  13. Kosinski M, Gajria K, Fernandes AW, Cella D: Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus. Lupus 2013;22:422-430.
  14. Lai JS, Beaumont JL, Ogale S, et al.: Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol 2011;38:672-679.
  15. Acaster S, Dickerhoof R, DeBusk K, et al.: Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes 2015;13:60.
  16. Kwakkenbos L, Willems LM, Baron M, et al.: The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): An assessment of differential item functioning in patients with systemic sclerosis. PLoS One 2014;9:e91979.
  17. Cella D, Lai JS, Chang CH, et al.: Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002;94:528-538.
  18. Shahvarughi A, Azimian M, Fallahpour M, Karimlou M: Evaluation of reliability and validity of the Persian version of fatigue severity scale (FSS) among persons with multiple sclerosis. Arch Rehabil 2013;13:84-91.
  19. Heidari M, Akbarfahimi M, Salehi M, Nabavi SM: Survey validity of translation for Persian and cultural adaptation of fatigue impact scale (FIS) questionnaire in multiple sclerosis patients in Iran. J Mod Rehabil 2012;6:20-29.
  20. Fereshtenejad SM, Hadizadeh H: Reliability and validity of the Persian version of the fatigue severity scale in idiopathic parkinson's disease patients. Parkinsons Dis 2013;2013:935429.
  21. Functional Assessment of Chronic Illness Therapy (FACIT): Recommended guidelines and procedures for translation2013. Retrieved from http://www.facit.org/about/welcome.aspx (accessed 20 September 2013).
  22. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
  23. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S: The hospital anxiety and depression scale (HADS): Translation and validation study of the Iranian version. Health Qual Life Outcomes 2003;1:14.
  24. Marx RG, Menezes A, Horovitz L, et al.: A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol 2003;56:730-735.
  25. Edge S, Byrd DR, Compton CC, et al.: AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual: Springer, New York, 2010.
  26. Jacobsen PB: Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004;32:93-97.
    External Resources
  27. Brown LF, Kroenke K: Cancer-related fatigue and its associations with depression and anxiety: A systematic review. Psychosomatics 2009;50:440-447.
  28. Ishikawa NM, Thuler LC, Giglio AG, et al.: Validation of the Portuguese version of functional assessment of cancer therapy-fatigue (FACT-F) in Brazilian cancer patients. Support Care Cancer 2010;18:481-490.
  29. Yoshimura A, Kobayashi K, Fumimoto H: Crosscultural validation of the Japanese functional assessment of cancer therapy-anemia (FACT-An). J Nippon Med Sch 2004;71:314-322.
  30. Wang SY, Zang XY, Liu JD, et al.: Psychometric properties of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Chinese patients receiving maintenance dialysis. J Pain Symptom Manage 2015;49:135-143.
  31. Banthia R, Malcarne VL, Ko CM, et al.: Fatigued breast cancer survivors: the role of sleep quality, depressed mood, stage and age. Psychol Health. 2009;24:965-980.
  32. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 2002;52:69-77.
  33. Kim SH, Son BH, Hwang SY, et al.: Fatigue and depression in disease-free breast cancer survivors: Prevalence, correlates, and association with quality of life. J Pain Symptom Manage 2008;35:644-655.
  34. Servaes P, Verhagen C, Bleijenberg G: Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer 2002;38:27-43.
  35. Miaskowski C, Dodd M, Lee K: Symptom clusters: The new frontier in symptom management research. J Natl Cancer Inst Monogr 2004;32:17-21.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Article

Received: November 08, 2016
Accepted: July 19, 2017
Published online: November 29, 2017
Issue release date: December 2017

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 2

ISSN: 2296-5270 (Print)
eISSN: 2296-5262 (Online)

For additional information: https://www.karger.com/ORT


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.